CTNI-17. A PHASE 1 WITH DOSE EXPANSION/PHASE 2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA
Article
Odia, Yazmin, Wen, Patrick, Mehta, Minesh et al. (2021). CTNI-17. A PHASE 1 WITH DOSE EXPANSION/PHASE 2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA
. NEURO-ONCOLOGY, 23(Supplement_6), vi62-vi63. 10.1093/neuonc/noab196.242
Odia, Yazmin, Wen, Patrick, Mehta, Minesh et al. (2021). CTNI-17. A PHASE 1 WITH DOSE EXPANSION/PHASE 2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA
. NEURO-ONCOLOGY, 23(Supplement_6), vi62-vi63. 10.1093/neuonc/noab196.242